e-learning
resources
Madrid 2019
Monday, 30.09.2019
COPD clinical studies: bronchodilators, corticosteroids and more
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characteristics and treatment patterns of newly diagnosed COPD patients in Canada
N. Dhalwani (London, United Kingdom), C. Cabrera (Mölndal, Sweden), A. Booth (London, United Kingdom), R. Petrella (London, Canada), D. Lambrelli (London, United Kingdom)
Source:
International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Session:
COPD clinical studies: bronchodilators, corticosteroids and more
Session type:
Poster Discussion
Number:
3385
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Dhalwani (London, United Kingdom), C. Cabrera (Mölndal, Sweden), A. Booth (London, United Kingdom), R. Petrella (London, Canada), D. Lambrelli (London, United Kingdom). Characteristics and treatment patterns of newly diagnosed COPD patients in Canada. 3385
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Comparison of characteristics of COPD patients with an established diagnosis, with those newly identified through case-finding – The Birmingham COPD cohort study
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014
Prevalence of comorbidities in established and newly treated patients with COPD according to GOLD 2017 in a UK primary care population
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
Characteristics of ICU-deaths in patients with COPD in Romania
Source: Eur Respir J 2003; 22: Suppl. 45, 445s
Year: 2003
Characterisation of patients with COPD in Scotland
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012
Patterns of co-morbidities in newly diagnosed asthma
Source: Annual Congress 2010 - From diagnosis to disease management in primary care
Year: 2010
Treatment patterns in the first four quarters following an incident COPD diagnosis in the UK
Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD
Year: 2010
Differences between newly and previously diagnosed COPD patients in a spirometry program
Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care
Year: 2009
Clinical characteristics and determinants of exacerbation in Japanese patients with COPD: Hokkaido COPD cohort study results
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021
Dual bronchodilation in real-life COPD management: analysis of patients’ characteristics enrolled in COPD Registry in Russia
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020
The characteristics of COPD patients recently diagnosed at an outpatient clinic
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006
Patients at risk for COPD compared to patients diagnosed with COPD
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
Prevalence and characteristics of COPD patients admitted for COVID-19 during the first wave.
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021
Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Comparison of inhaler device preference of the physicians in the treatment of newly diagnosed adult asthma and COPD patients
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019
Antecedent hospitalization history of patients newly diagnosed with COPD
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020
Characteristics of younger versus elderly patients with pulmonary tuberculosis diagnosed at respiratory department
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
The clinical impact of long-acting bronchodilators in newly diagnosed COPD patients
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept